Although randomised clinical trials (RCTs) remain the gold standard for evaluating the benefit/risk of cancer drugs, single-arm trials (SATs) can provide invaluable opportunities to speed up cancer drug development and approval, ...
Oct 11, 2016
Saxagliptin (trade name: Onglyza) is approved for adults with type 2 diabetes mellitus whose blood-glucose levels are inadequately controlled by diet and exercise alone. The fixed combination with metformin is available under ...
Oct 11, 2016
Ibrutinib was approved in 2014 for the treatment of certain adults with chronic lymphocytic leukaemia (CLL), particularly as second-line treatment. The therapeutic indication was expanded in 2016. The drug is now also approved ...
Oct 11, 2016
A treatment harnesses the immune system to shrink tumors in bladder cancer patients that cannot take the most effective chemotherapy.
Oct 11, 2016
The rise in incidence of oropharyngeal squamous cell carcinoma in the United Kingdom from 2002 to 2011 was not solely attributable to a rise in incidence of human papillomavirus (HPV)-positive disease because the proportion ...
Oct 11, 2016
Researchers from the University Health Network (UHN); Toronto Western Neurosurgery Division and MacFeeters Hamilton Neuro-oncology Program at the Princess Margaret Cancer Centre have described the genomic landscape of schwannomas ...
Oct 11, 2016
Replacing the maximum Supplemental Nutrition Assistance Program (SNAP) allotment with a benefit that reflects the real cost of a healthy diet, expanding the Special Supplemental Nutrition Program for Women, Infants, and Children ...
Oct 11, 2016
Forty per cent of people say that having to talk through their symptoms with doctors' receptionists could put them off going to their GP, according to an analysis of the Cancer Awareness Measure (CAM) published today (Tuesday) ...
Oct 11, 2016
